Oligonucleotide Therapeutics Market Revenue 2024 to 2034
Oligonucleotide Therapeutics Market Revenue 2024 to 2034
The global oligonucleotide therapeutics market, valued at USD 9.32 Bn in 2024, is projected to reach USD 31.64 Bn by 2034, growing at a 13% CAGR driven by rising demand for precision medicine and RNA-based therapies.
Report ID: 10389
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 9.32 Bn
Forecast Year,
USD 31.64 Bn
CAGR, 2025 -
13.00%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Oligonucleotide Therapeutics Market Size Analysis
Oligonucleotide Therapeutics Market Size By Therapy & Class 2024 to 2034 (USD )
| Therapy & Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 2.98 | 3.39 | 3.84 | 4.33 | 4.89 | 5.55 | 6.26 | 7.05 | 7.93 | 8.92 | 10.14 |
| Biologics | 3.17 | 3.57 | 4.05 | 4.59 | 5.16 | 5.80 | 6.52 | 7.35 | 8.34 | 9.44 | 10.67 |
| Advanced Therapies | 1.68 | 1.88 | 2.11 | 2.38 | 2.69 | 3.05 | 3.47 | 3.95 | 4.47 | 5.05 | 5.67 |
| Others | 1.49 | 1.69 | 1.90 | 2.15 | 2.45 | 2.78 | 3.15 | 3.58 | 4.04 | 4.59 | 5.16 |
Oligonucleotide Therapeutics Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 3.36 | 3.80 | 4.29 | 4.87 | 5.48 | 6.14 | 6.93 | 7.87 | 8.85 | 9.92 | 11.22 |
| Cardio-Metabolic | 1.68 | 1.89 | 2.13 | 2.38 | 2.69 | 3.05 | 3.44 | 3.89 | 4.39 | 5.02 | 5.69 |
| Infectious | 1.49 | 1.69 | 1.91 | 2.16 | 2.44 | 2.78 | 3.14 | 3.53 | 4.02 | 4.55 | 5.17 |
| CNS | 1.30 | 1.47 | 1.66 | 1.88 | 2.14 | 2.42 | 2.73 | 3.08 | 3.47 | 3.93 | 4.45 |
| Others | 1.49 | 1.69 | 1.91 | 2.16 | 2.45 | 2.79 | 3.17 | 3.56 | 4.05 | 4.57 | 5.11 |
Oligonucleotide Therapeutics Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 4.10 | 4.66 | 5.24 | 5.86 | 6.62 | 7.44 | 8.44 | 9.52 | 10.77 | 12.21 | 13.83 |
| Retail Pharmacy | 3.36 | 3.76 | 4.27 | 4.85 | 5.48 | 6.26 | 7.07 | 7.99 | 9.01 | 10.11 | 11.44 |
| Online/Other | 1.86 | 2.12 | 2.39 | 2.73 | 3.10 | 3.47 | 3.90 | 4.41 | 5.00 | 5.68 | 6.36 |
Oligonucleotide Therapeutics Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.73 | 4.20 | 4.74 | 5.35 | 6.03 | 6.76 | 7.65 | 8.69 | 9.85 | 11.13 | 12.53 |
| Europe | 2.61 | 2.94 | 3.32 | 3.78 | 4.28 | 4.85 | 5.49 | 6.17 | 6.94 | 7.84 | 8.88 |
| Asia Pacific | 2.24 | 2.55 | 2.88 | 3.25 | 3.68 | 4.19 | 4.72 | 5.32 | 6.01 | 6.79 | 7.69 |
| Latin America | 0.37 | 0.42 | 0.48 | 0.54 | 0.61 | 0.68 | 0.77 | 0.87 | 0.99 | 1.11 | 1.27 |
| Middle East & Africa | 0.37 | 0.42 | 0.48 | 0.54 | 0.61 | 0.69 | 0.78 | 0.88 | 0.99 | 1.12 | 1.26 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
